Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04891510

A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
135 (estimated)
Sponsor
Weill Medical College of Cornell University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.

Conditions

Interventions

TypeNameDescription
DEVICEREVOLVE Advanced Adipose SystemThe REVOLVE system is an all-in-one fat processing device that harvests, filters, actively washes, and removes strands from lipoaspirate and allows for reinjection without any additional manipulation (REVOLVE 2020).
DEVICELipoGrafterThe LipoGrafter system is designed to be a start-to-finish closed system with minimal processing of the lipoaspirate, minimizing the risk of contamination and fat cell damage (LipoGrafter 2020).
PROCEDUREVialityThe Viality system uses the AuraClens solution that acts as a surfactant to bring impurities like blood, free oil, and cellular debris into solution, where they can be flushed out through suction.

Timeline

Start date
2021-05-19
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2021-05-18
Last updated
2025-07-31

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04891510. Inclusion in this directory is not an endorsement.